These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33067907)

  • 1. In vitro and in vivo performance modelling and optimisation of different dry powder inhalers: A complementary study of neural networks, genetic algorithms and decision trees.
    Ali AMA; Zawbaa HM; Sayed OM; Harb HS; Saeed H; Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Salem MN; Rabea H; Wael W; Hussein RRS; Sarhan RM; Ramadan W; Madney YM; Abdelrahim MEA
    Int J Clin Pract; 2021 Mar; 75(3):e13764. PubMed ID: 33067907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled salbutamol from aerolizer and diskus at different inhalation flows, inhalation volume and number of inhalations in both healthy subjects and COPD patients.
    Boshra MS; Almeldien AG; Eldin RS; Elberry AA; Abdelwahab NS; Salem MN; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2019; 45(3-4):84-91. PubMed ID: 31155973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.
    Boshra MS; Almeldien AG; Salah Eldin R; Elberry AA; Abdelwahab NS; Nabil Salem M; Rabea H; Abdelrahim MEA
    Exp Lung Res; 2018; 44(4-5):211-216. PubMed ID: 30346848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.
    Buttini F; Brambilla G; Copelli D; Sisti V; Balducci AG; Bettini R; Pasquali I
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):167-78. PubMed ID: 26355743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.
    Chrystyn H; Price DB; Molimard M; Haughney J; Bosnic-Anticevich S; Lavorini F; Efthimiou J; Shan D; Sims E; Burden A; Hutton C; Roche N
    BMC Pulm Med; 2016 Jan; 16():12. PubMed ID: 26769482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
    Moore A; Riddell K; Joshi S; Chan R; Mehta R
    J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhalation characteristics of patients when they use different dry powder inhalers.
    Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalation profiles in asthmatics and COPD patients: reproducibility and effect of instruction.
    Broeders ME; Molema J; Hop WC; Folgering HT
    J Aerosol Med; 2003; 16(2):131-41. PubMed ID: 12823907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Comparison of Two Blister-Type Inhalers.
    Kondo T; Tanigaki T; Hibino M; Tajiri S; Horiuchi S; Maeda K; Tobe S
    Respir Care; 2023 Mar; 68(3):338-345. PubMed ID: 36100278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.
    Delvadia R; Hindle M; Longest PW; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):138-44. PubMed ID: 22947131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhalation immediately before inhalation optimizes dry powder inhaler use.
    Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
    J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices.
    Lipworth BJ; Clark DJ
    Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer modeling of airway deposition distribution of Foster(®) NEXThaler(®) and Seretide(®) Diskus(®) dry powder combination drugs.
    Jókay Á; Farkas Á; Füri P; Horváth A; Tomisa G; Balásházy I
    Eur J Pharm Sci; 2016 Jun; 88():210-8. PubMed ID: 26976481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults.
    Melani AS; Zanchetta D; Barbato N; Sestini P; Cinti C; Canessa PA; Aiolfi S; Neri M;
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):439-46. PubMed ID: 15562882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of powder residence time for the aerosol delivery performance of a commercial dry powder inhaler Aerolizer(®).
    Jiang L; Tang Y; Zhang H; Lu X; Chen X; Zhu J
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):265-79. PubMed ID: 22280548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.
    Kondo T; Hibino M; Tanigaki T; Tajiri S; Horiuchi S
    J Aerosol Med Pulm Drug Deliv; 2021 Aug; 34(4):223-230. PubMed ID: 33147100
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
    Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
    Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dry powder inhalers in COPD.
    Wilson DS; Gillion MS; Rees PJ
    Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
    de Matas M; Shao Q; Richardson CH; Chrystyn H
    Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.